Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP)

Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Azioni (FBIOP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	16.71%18.72	16.04	16.08	17.63	16.41
Cost Of Revenue	1.21%6.14	6.22	5.44	5.76	4.94
	30.92%20.81	15.89	14.73	17.42	38.76
Selling, General, and Administrative	30.92%20.81	15.89	14.73	17.42	38.76
Costs And Expenses	20.81%28.72	23.78	20.87	24.44	52.89
Operating Income/Loss	29.29%-10.01	-7.74	-4.79	-6.81	-36.47
Nonoperating Income/Loss	92.72%10.93	150.03	-1.42	15.66	24.82
Income/Loss From Continuing Operations Before Tax	99.35%0.92	142.29	-6.21	8.85	-
Income Tax Expense/Benefit	93.76%0.32	5.13	-0.82	0.03	-
	99.56%0.60	137.16	-5.40	8.83	-11.65
Attributable To Parent	100.42%-0.47	110.37	-3.94	5.85	15.49
Available To Common Stockholders, Basic	102.28%-2.48	108.37	-6.20	3.68	13.36
Preferred Stock Dividends And Other Adjustments	2.01	2.01	2.26	2.17	-
	96.01%1.07	26.79	-1.46	2.98	-27.14
Nonredeemable Noncontrolling Interest	96.01%-1.07	-26.79	1.46	-2.98	27.14
Basic Average Shares	0.79%31.79	31.54	-	27.24	26.88
Diluted Average Shares	17.24%31.79	38.41	-	33.10	29.82
Basic Earnings Per Share	102.33%-0.08	3.44	-	0.13	0.50
Diluted Earnings Per Share	102.84%-0.08	2.82	-	0.11	0.45